Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium oxide vs macrogol/electrolytes to prevent opioid-induced constipation in palliative cancer care
2007-007610-10Phase 3Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in constipation, cancer pain and cancer comparing Magnesium oxide with Movicolon (2 arms). Primary endpoint: Constipation severity (PAC-SYM). Started Aug 2008; status: terminated.
02
Drugs
magnesium oxidemacrogol + potassium chloride + sodium chloride + sodium bicarbonate
03
Conditions
constipationcancer paincancer
Beyond the preview
Go deeper on 2007-007610-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007610-10.